{"name":"Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León","slug":"fundaci-n-instituto-de-estudios-de-ciencias-de-la-salud-de-castilla-y-le-n","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Allogenic MSCs","genericName":"Allogenic MSCs","slug":"allogenic-mscs","indication":"Graft-versus-host disease (GVHD)","status":"phase_3"},{"name":"VERDYE powder for solution for injection 25 mg","genericName":"VERDYE powder for solution for injection 25 mg","slug":"verdye-powder-for-solution-for-injection-25-mg","indication":"Other","status":"marketed"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Autologous MSCs","genericName":"Autologous MSCs","slug":"autologous-mscs","indication":"Cartilage defects and osteoarthritis (likely primary indication based on MSC development history)","status":"phase_3"}]}],"pipeline":[{"name":"Allogenic MSCs","genericName":"Allogenic MSCs","slug":"allogenic-mscs","phase":"phase_3","mechanism":"Allogeneic mesenchymal stem cells (MSCs) exert immunomodulatory and regenerative effects by secreting anti-inflammatory cytokines and promoting tissue repair.","indications":["Graft-versus-host disease (GVHD)","Tissue repair and regeneration"],"catalyst":""},{"name":"Autologous MSCs","genericName":"Autologous MSCs","slug":"autologous-mscs","phase":"phase_3","mechanism":"Autologous mesenchymal stem cells (MSCs) are harvested from the patient's own bone marrow or adipose tissue and administered to promote tissue repair and modulate immune responses.","indications":["Cartilage defects and osteoarthritis (likely primary indication based on MSC development history)"],"catalyst":""},{"name":"VERDYE powder for solution for injection 25 mg","genericName":"VERDYE powder for solution for injection 25 mg","slug":"verdye-powder-for-solution-for-injection-25-mg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":3,"phaseCounts":{"phase_3":2,"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}